Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002183151 | SCV002429112 | benign | not provided | 2022-04-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004046407 | SCV002754843 | uncertain significance | not specified | 2018-05-14 | criteria provided, single submitter | clinical testing | The p.Y950C variant (also known as c.2849A>G), located in coding exon 2 of the KIAA2022 gene, results from an A to G substitution at nucleotide position 2849. The tyrosine at codon 950 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species, and cysteine is the reference amino acid in other vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |